C07F 9/2458
Of aliphatic amines
Official title: {of aliphatic amines}
C07F9/2458 (Of aliphatic amines) appears on 212 US grants and 152 published applications in this corpus.
Search patents in C07F- Granted patents
- 212
- Published applications
- 152
- Assignees
- 150
- Inventors
- 525
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 12 | 0 |
| 1977 | 7 | 0 |
| 1978 | 4 | 0 |
| 1979 | 8 | 0 |
| 1980 | 9 | 0 |
| 1981 | 4 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 4 | 0 |
| 1986 | 3 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 5 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 7 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 6 | 0 |
| 2002 | 1 | 2 |
| 2003 | 3 | 1 |
| 2004 | 1 | 3 |
| 2005 | 2 | 6 |
| 2006 | 3 | 7 |
| 2007 | 4 | 6 |
| 2008 | 2 | 5 |
| 2009 | 1 | 1 |
| 2010 | 5 | 13 |
| 2011 | 2 | 5 |
| 2012 | 10 | 4 |
| 2013 | 3 | 3 |
| 2014 | 10 | 12 |
| 2015 | 6 | 9 |
| 2016 | 10 | 11 |
| 2017 | 4 | 5 |
| 2018 | 7 | 11 |
| 2019 | 9 | 13 |
| 2020 | 11 | 4 |
| 2021 | 5 | 3 |
| 2022 | 3 | 2 |
| 2023 | 4 | 11 |
| 2024 | 3 | 6 |
| 2025 | 1 | 7 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Solid supports and phosphoramidite building blocks for oligonucleotide conjugates15 Sep 2026US 12,735,387 B2AM Chemicals LLC
- Probe related reagents and methods2 Jun 2026US 12,643,916 B2Brentano Biotechnology Associates
- Anti-inflammatory, anti-cancer, and anti-angiogenic compounds, pharmaceutical compositions, and methods of making and using thereof14 Apr 2026US 12,599,599 B2Medicon Pharmaceuticals, Inc.
- Gamma-hydroxybutyrate delivering compounds and processes for making and using them18 Mar 2025US 12,251,445 B2Zevra Therapeutics, Inc.
- Acyclic thiol prodrugs14 May 2024US 11,981,694 B2Lilac Therapeutics, Inc.
- Akr1c3-activated dna alkylating agent, and medical application thereof11 Jun 2026US 2026/0159536 A1Ascentawits Pharmaceuticals, Ltd.
- Phosphatidylamine compounds including a plurality of tertiary amino group structures and compositions thereof26 Mar 2026US 2026/0085081 A1Peking University
- 18f-labeled psma-targeted pet imaging agents11 Dec 2025US 2025/0375542 A1Cancer Targeted Technology LLC
- Gamma-hydroxybutyrate delivering compounds and processes for making and using them4 Dec 2025US 2025/0367299 A1Zevra Therapeutics, Inc.
- Probe related reagents and methods31 Jul 2025US 2025/0243540 A1Brentano Biotechnology Associates
Most cited
By later US patents
- Methods for the preparation of diasteromerically pure phosphoramidate prodrugs97US 9,090,642 B2Gilead Sciences, Inc. · 2015
- Oligonucleotide functionalizing reagents92US 4,914,210 ACetus Corporation · 1990
- Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof75US 6,511,990 B1Sloan-Kettering Institute for Cancer Research · 2003
- Stereoselective synthesis of phosphorus containing actives58US 8,859,756 B2Gilead Pharmasset LLC · 2014
- Aminoacid derivatives as antihypertensives51US 4,316,896 AMerck & Co., Inc. · 1982